Obesity has a protective effect on radiographic joint damage in rheumatoid arthritis

##plugins.themes.academic_pro.article.sidebar##

Published May 9, 2011
Download
pdf
Vol. 89 No. 5 (2011): Issue May 2011

##plugins.themes.academic_pro.article.main##

Raoudha Tekaya
Hana Sahli
Saida Zribi
Ines Mahmoud
Chiraz Ben Hadj Yahia
Leila Abdelmoula
Lilia Chaabouni
Rafik Zouari

Abstract

Background: Obesity is a state of chronic low-grade inflammation that predisposes people to several diseases and that is increasingly prevalent. Rheumatoid arthritis (RA) is marked by the presence of proinflammatory cytokines and, in general, the presence of high levels of inflammatory markers is associated with a severe disease course and joint damage.
Aim: To assess the impact of obesity on disease activity, quality of life and articular damage in patients with established RA.
Methods: Between July 2009 to December 2009, 119 RA patients were included and divided in two groups according to the body mass index (obeses and controls). RA activity was assessed by the Disease Activity Score (DAS) 28, quality of life by the Health Assessment Questionnary (HAQ) and radiographic joint damage by the modified Sharp score.
Results: Obesity wasn’t correlated with worsen RA activity (p=0.71) nor quality of life impairment (p=0.51).
The obese group had a lower modified Sharp score than the control group (64.97versus113.64; p < 0.032) and this association remained significant after adjustment for age, sex, disease activity, extraarticular manifestations, comorbidities, presence of rheumatoid factor, and disease duration.
Conclusion: Obesity does not have an impact on disease activity nor changes in quality of life, but it has a protective effect on the amount of joint destruction in established rheumatoid arthritis.

Keywords:

Rheumatoid arthritis, Obesity, Quality of life, Modified Sharp score, DAS 28

##plugins.themes.academic_pro.article.details##

References

  1. Merrouche M, Coffin B. Obésité : prise en charge, indications et méthodes du traitement endoscopique et chirurgical. EMCHépatologie- gastro-entérologie 2005;2:189-200.
  2. Pérusse L. Génétique de l'obésité. EMC-Endocrinologie 2004;1:67-80.
  3. Kamoun M, Hajem S, Imen S et al. Prevalence of obesity and overweight in Tunisia on 2001. Tunis Med. 2008;86: 649-52.
  4. Poitou C, Clément K. Le tissu adipeux : un acteur majeur du syndrome inflammatoire de l'obésité? Cah Nutr Diet 2007;42: 90-6.
  5. Dugail I. New insights into adipose cell biology. Ann Pharm Fr. 2004; 62:87-91.
  6. Basdevant A. Obesity: Pathophysiological concepts. Joint Bone Spine. 2008; 75:665-6
  7. Basdevant A. Rôle délétère du tissu adipeux sur les maladies cardiovasculaires Ann Cardiol Angeiol 2002 ;51: 346-50.
  8. Ritchie SA, Connell JMC. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17:319-26.
  9. Y Allanore, N Assous, J Wipff et al. Forte prévalence de l'obésité et du surpoids au cours des rhumatismes inflammatoires. Rev du Rhum 2006; 73:1143-4.
  10. Garcia-Poma A, Segami MI, Mora CS et al. Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis. Clin Rheumatol. 2007, 26: 1831-5.
  11. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF. Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol 2009; 28:439-44.
  12. Engel SG, Crosby RD, Kolotkin RL et al. Impact of weight loss and regain on quality of life: mirror image or differential effect? Obes Res 2003; 11: 1207-13.
  13. Lafontan M. Tissu adipeux : glande endocrine polyvalente. Cah Nutr Diet 2007;42:79-83.
  14. Clément K, Vignes S. Inflammation, adipokines et obésité. Rev Med Int 2009; 30:824-32.
  15. Westhoff G, Rau R, Zink A. Radiographic joint damage in early rheumatoid arthritis is highly dependent on body mass index. Arthritis Rheum 2007;56: 3575-82.
  16. Magliano M. Obesity and arthritis. Menopause Int 2008; 14: 149-54.
  17. Kaufmann J, Kielstein V, Kilian S et al. Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol 2003; 30: 2350-5.
  18. Carlsten H. Immune responses and bone loss: the estrogen connection. Immunol Rev 2005; 208: 194-206.
  19. Castracane VD, Kraemer GR, Ogden BW et al. Interrelationships of serum estradiol, estrone, and estrone sulfate, adiposity, biochemical bone markers, and leptin in post-menopausal women. Maturitas 2006; 53: 217-25.
  20. Oh KW, Lee WY, Rhee EJ, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol 2005; 63: 131-8.